NDC 68084-964-95 - Propylthiouracil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-964
- Requested NDC
- 68084-964-95
- Package NDCs from labels
- 68084-964-95, 68084-964-25
- Manufacturer
- American Health Packaging
- Effective date
- 2026-08-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Propylthiouracil - American Health Packaging | American Health Packaging | 2026-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-964-25 | Propylthiouracil | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 6 | |
| 68084-964-95 | Propylthiouracil | 1 in 1 BLISTER PACK | TABLET | 1 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-964-25 | EA - Each | 68084-964 | 090b7279-df0b-4fa8-8733-5703f698259b | 1 | 2015-11-12 |
| 68084-964-95 | EA - Each | 68084-964 | ad1ba66a-b99e-49f2-9006-51412d70143e | 1 | 2015-11-12 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PROPYLTHIOURACIL | ACTIVE INGREDIENT | 721M9407IY | PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| PROPYLTHIOURACIL | ACTIVE MOIETY | 721M9407IY | PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| SODIUM GLYCOLATE | INACTIVE INGREDIENT | B75E535IMI | PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | PROPYLTHIOURACIL TABLET [AMERICAN HEALTH PACKAGING] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Regular Strength | DOCUSATE SODIUM | Sam's West, Inc | 1eca5910-b0bf-4e07-8211-36dba52b3de7 | 2026-01-06 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Safeway, Inc. | acb40b29-5fd5-4864-b6bf-4102e47a1683 | 2026-01-05 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES AND DOCUSATE SODIUM | RMT HEALTH LLC | 4742182e-fdf9-44fe-e063-6394a90adfcc | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | 2d8bdd3e-f6e6-43f5-b3b0-e5a882cae41c | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Senna-S | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | Walgreens | 36cc3a5b-1891-d39e-e063-6294a90a93b4 | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM | RUGBY LABORATORIES | e21d19d8-6c2d-4474-a663-dfe7e91ac320 | 2025-12-30 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNA-S | Pioneer Life Sciences, LLC | ab46a3ca-6c7a-a81e-e053-2995a90a199f | 2025-12-29 | Warnings | F05Q2T2JA0 |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Pharbest Pharmaceuticals, Inc. | 2b5152b2-d354-409f-a19f-b470f4181b3f | 2025-12-24 | Warnings | F05Q2T2JA0 |
| Senna Plus | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | CARDINAL HEALTH, 110 DBA LEADER | 4d4101ca-7d78-4712-9b3d-f395f2646c6b | 2025-12-23 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG | NUVICARE LLC | 9e999e4a-2f72-4a2b-a41b-bdd68bf5a350 | 2025-12-19 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | cb0765cb-f48e-4daa-97b8-2897a2d95587 | 2025-12-19 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Strategic Sourcing Services LLC | ba51cca1-b70b-476e-80e6-20cd52292e65 | 2025-12-17 | Warnings | F05Q2T2JA0 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | CVS Pharmacy | a694b4f3-6112-4a1d-a06e-9e5b20fd3d7b | 2025-12-17 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | CARDINAL HEALTH 110, LLC. DBA LEADER 70000 | da5ccd75-8a2f-4f90-ae8a-97d81b8579d2 | 2025-12-17 | Warnings | F05Q2T2JA0 |
| Senna Plus | DOCUSATE SODIUM, SENNOSIDES | CVS Pharmacy | ae9d1672-9ade-4139-9126-5289b87fe574 | 2025-12-17 | Warnings | F05Q2T2JA0 |
| GeriCare Docusate Sodium Liquid | DOCUSATE SODIUM | GERI-CARE PHARMACEUTICALS, CORP | d599ff49-c9a4-401a-a50b-63d89749bbed | 2025-12-11 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | Major Pharmaceuticals | 3e8321cf-7eda-d70c-e063-6394a90a35a5 | 2025-12-10 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | HEB | 2f103a88-4cab-d4b9-e063-6394a90ac7fc | 2025-12-09 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | HEB | 2efb4c5a-2c5e-acf6-e063-6394a90a934e | 2025-12-08 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.